On 26 April 2019, the NAMPAR project, in which ZIB and Charité jointly developed a drug candidate for pain therapy, received the second prize "VIP+ Validation Prize 2019". The prize was awarded to the cooperation partners for the successful validation of drug effects predicted on the computer. The Charité press release can be found here:
Links